In our study, we observed a slight increase in YAP/TAZ expression in K19+ HCC compared to K19− HCC, although the number of K19+ HCC cases was too few to draw statistically significant conclusions or to perform a survival analysis. Here, YAP1 is linked to hepatocellular carcinoma.